Company Filing History:
Years Active: 2019-2024
Title: Babak Alipanahi: Innovator in Genetic Variant Interpretation
Introduction
Babak Alipanahi is a prominent inventor based in Toronto, Canada, known for his contributions to the field of genomics. With a total of two patents to his name, Alipanahi has made significant strides in the classification and interpretation of genetic variants, leveraging advanced technologies such as deep neural networks.
Latest Patents
Alipanahi's latest patents focus on "Systems and methods for classifying, prioritizing and interpreting genetic variants and therapies using a deep neural network." These inventions describe novel systems that take DNA or RNA sequences as input, extracting features and applying various layers of processing units to determine condition-specific cell variables. This innovative approach aims to assess how genetic variants impact cellular responses under diverse conditions. By calculating changes in these variables, the patented systems can compute scores reflecting the deleteriousness of variants, allowing classification and prioritization for further analysis. Moreover, the systems can incorporate the effects of various therapies, such as DNA editing, to evaluate the potential reduction of deleterious effects from specific genetic variants.
Career Highlights
Alipanahi is associated with Deep Genomics Incorporated, a company specializing in the use of artificial intelligence to advance genetic medicine. His work focuses on creating groundbreaking methods that enhance the understanding and treatment of genetic disorders, aligning with the company's mission to transform drug discovery through AI.
Collaborations
Throughout his career, Alipanahi has collaborated with notable colleagues, including Brendan John Frey and Michael K K Leung. These collaborations foster an environment of innovation and shared expertise, contributing to the development of cutting-edge solutions in the realm of genetic interpretation.
Conclusion
Babak Alipanahi stands out as an innovative figure in the landscape of genetic research, combining his expertise in deep learning with a keen understanding of genetics. His patents demonstrate a commitment to advancing healthcare through technology, and his contributions to Deep Genomics Incorporated position him as a vital player in the future of genomic medicine.